バルノクタミド
Wikipedia preview
出典(authority):フリー百科事典『ウィキペディア(Wikipedia)』「2014/07/21 02:20:18」(JST)
[Wiki en表示]
Valnoctamide |
|
IUPAC name
2-Ethyl-3-methylpentanamide[1]
|
Identifiers |
CAS number |
4171-13-5 N |
PubChem |
20140, 36689722 2R,3R, 10313196 2R,3S, 25271745 2S,3R, 12015994 2S,3S |
ChemSpider |
18974 Y, 8488661 2R,3S Y |
UNII |
3O25NRX9YG Y |
EC number |
224-033-7 |
KEGG |
D02717 N |
MeSH |
valnoctamide |
ChEMBL |
CHEMBL1075733 Y |
RTECS number |
YV5950000 |
ATC code |
N05CM13 |
Jmol-3D images |
Image 1
Image 2 |
-
CCC(C)C(CC)c(:[nH2]):[o]
CCC(C)C(CC)C(N)=O
|
-
InChI=1S/C8H17NO/c1-4-6(3)7(5-2)8(9)10/h6-7H,4-5H2,1-3H3,(H2,9,10) Y
Key: QRCJOCOSPZMDJY-UHFFFAOYSA-N Y
|
Properties |
Molecular formula |
C8H17NO |
Molar mass |
143.23 g mol−1 |
Appearance |
White crystals |
log P |
1.885 |
Pharmacology |
Bioavailability |
94% |
Routes of
administration |
|
Metabolism |
Hepatic |
Elimination
half-life |
10 hours |
Hazards |
GHS pictograms |
|
GHS signal word |
WARNING |
GHS hazard statements |
H302 |
EU classification |
Xn |
R-phrases |
R22 |
LD50 |
760 mg kg−1 (oral, rat) |
Related compounds |
Related alkanamides |
Valpromide |
Related compounds |
- 2-Methylpentane
- 3-Methylpentane
- 3-Ethylpentane
- 2-Ethyl-1-butanol
- 2-Methylhexane
- 3-Methylhexane
- 2-Methylheptane
- 3-Methylheptane
- 2-Ethylhexanol
- 2-Ethylhexanoic acid
|
Except where noted otherwise, data are given for materials in their standard state (at 25 °C (77 °F), 100 kPa) |
N (verify) (what is: Y/N?) |
Infobox references |
|
|
Valnoctamide (INN, USAN) has been used in France as a sedative-hypnotic since 1964.[2] It is a structural isomer of valpromide, a valproic acid prodrug; unlike valpromide, however, valnoctamide is not transformed into its homologous acid, valnoctic acid, in vivo.[3]
Contents
- 1 Indications
- 2 Side effects
- 3 Interactions
- 4 Chemistry
- 5 References
Indications
In addition to being a sedative, valnoctamide has been investigated for use in epilepsy since 1969[4] and was still being investigated in 2000[5] and 2003.
It was studied for neuropathic pain in 2005 by Winkler et al., with good results: it had minimal effects on motor coordination and alertness at effective doses, and appeared to be equally effective as gabapentin.[6]
RH Belmaker, Yuly Bersudsky and Alex Mishory started a clinical trial of valnoctamide for prophylaxis of mania in lieu of the much more teratogenic valproic acid or its salts.[7]
Side effects
The side effects of valnoctamide are mostly minor and include somnolence and the slight motor impairments mentioned above.
Interactions
Valnoctamide is known to increase through inhibition of epoxide hydrolase the serum levels of carbamazepine-10,11-epoxide, the active metabolite of carbamazepine, sometimes to toxic levels.[8]
Chemistry
Valnoctamide is a racemic compound with four stereoisomers,[9] all of which were shown to be more effective than valproic acid in animal models of epilepsy and one of which [(2S,3S]-valnoctamide) was considered to be a good candidate by Isoherranen, et al. for an anticonvulsant in August 2003.[10]
References
- ^ "valnoctamide - Compound Summary". PubChem Compound. USA: National Center for Biotechnology Information. 26 March 2005. Identification and Related Records. Retrieved 20 February 2012.
- ^ Harl, F. M. (March 1964). "[Clinical Study Of Valnoctamide On 70 Neuropsychiatric Clinic Patients Undergoing Ambulatory Treatment]". La Presse Médicale (in French) 72: 753–754. PMID 14119722.
- ^ Haj-Yehia, Abdullah; Meir Bialer (August 1989). "Structure-pharmacokinetic relationships in a series of valpromide derivatives with antiepileptic activity". Pharmaceutical Research 6 (8): 683–689. doi:10.1023/A:1015934321764. PMID 2510141.
- ^ Mattos Nda, S. (May 1969). "[Use of Valnoctamide (nirvanil) in oligophrenic erethics and epileptics]". Hospital (Rio J) (in Portuguese) 75 (5): 1701–1704. PMID 5306499.
- ^ Lindekens, H.; Ilse Smolders, Ghous M. Khan, Meir Bialer, Guy Ebinger, and Yvette Michotte (November 2000). "In vivo study of the effect of valpromide and valnoctamide in the pilocarpine rat model of focal epilepsy". Pharmaceutical Research 17 (11): 1408–1413. doi:10.1023/A:1007559208599. PMID 11205735.
- ^ Winkler, Ilan; Simcha Blotnik, Jakob Shimshoni, Boris Yagen, Marshall Devor, and Meir Bialer (September 2005). "Efficacy of antiepileptic isomers of valproic acid and valpromide in a rat model of neuropathic pain". British Journal of Pharmacology 146 (2): 198–208. doi:10.1038/sj.bjp.0706310. PMC 1576263. PMID 15997234.
- ^ RH Belmaker, Yuly Bersudsky, Alex Mishory and Beersheva Mental Health Center (2005). "Valnoctamide in Mania". ClinicalTrials.gov. United States National Institutes of Health. Retrieved 25 February 2006.
- ^ Pisani, F; Fazio, A; Artesi, C; Oteri, G; Spina, E; Tomson, T; Perucca, E (1992). "Impairment of carbamazepine-10, 11-epoxide elimination by valnoctamide, a valpromide isomer, in healthy subjects". British Journal of Clinical Pharmacology 34 (1): 85–87. doi:10.1111/j.1365-2125.1992.tb04114.x. PMC 1381382. PMID 1352988.
- ^ Shimon Barel, Boris Yagen, Volker Schurig, Stephan Sobak, Francesco Pisani, Emilio Perucca and Meir Bialer. Stereoselective pharmacokinetic analysis of valnoctamide in healthy subjects and in patients with epilepsy. Clinical Pharmacology & Therapeutics 61, 442–449 (April 1997) doi:10.1016/S0009-9236(97)90194-6
- ^ Isoherranen, Nina; H. Steve White, Brian D. Klein, Michael Roeder, José H. Woodhead, Volker Schurig, Boris Yagen, Meir Bialer (August 2003). "Pharmacokinetic-pharmacodynamic relationships of (2S,3S)-valnoctamide and its stereoisomer (2R,3S)-valnoctamide in rodent models of epilepsy". Pharmaceutical Research 8 (8): 1293–1301. doi:10.1023/A:1025069519218. PMID 12948028.
Anticonvulsants (N03)
|
|
GABAA receptor agonist |
Barbiturates
|
- Barbexaclone
- Metharbital
- Methylphenobarbital
- Pentobarbital
- Phenobarbital#
- Primidone
|
|
Benzodiazepines
|
- Clobazam
- Clonazepam
- Clorazepate
- Diazepam#
- Flutoprazepam
- Lorazepam#
- Midazolam
- Nimetazepam
- Nitrazepam
- Temazepam
|
|
|
Other GABA agents |
Aromatic allylic alcohols
|
|
|
|
Carbonic anhydrase inhibitor |
Sulfa drugs
|
- Acetazolamide
- Ethoxzolamide
- Sultiame
- Zonisamide
|
|
|
Channel blockers |
Primarily sodium
|
Hydantoins
|
- Ethotoin
- Fosphenytoin
- Mephenytoin
- Phenytoin#
|
|
Carboxamides
|
- Carbamazepine#
- Eslicarbazepine acetate
- Oxcarbazepine
- Oxitriptyline
- Rufinamide
|
|
|
Primarily calcium
|
Succinimides
|
- Ethosuximide#
- Mesuximide
- Phensuximide
|
|
|
AMPA receptor
|
|
|
Unknown/ungrouped
|
- Phenyltriazine (Lamotrigine), Oxazolidinediones (Ethadione
- Paramethadione
- Trimethadione), Ureas (Phenacemide
- Pheneturide), Monosaccharide (Topiramate)
|
|
|
Channel openers |
|
|
Indirect GABA agents |
Carboxylic acids/
Fatty acid derivatives
|
- GABA transaminase inhibitor: Valproic acid# (Sodium valproate & Valproate semisodium)
- Valpromide
- Valnoctamide
- Valproate pivoxil
GABA reuptake inhibitor: Tiagabine
|
|
GABA analogs
|
- Gabapentin
- Pregabalin
- Progabide
- Tolgabide
- Vigabatrin
|
|
|
Unknown/multiple/
unsorted |
Carbamates/sulfamates
|
- Carisbamate†
- Emylcamate
- Felbamate
- JNJ-26990990§
- Meprobamate
- Topiramate
|
|
Pyrrolidines
|
- Brivaracetam
- Levetiracetam
- Nefiracetam
- Seletracetam
|
|
Propionates
|
|
|
Aldehydes
|
|
|
Bromides
|
- Potassium bromide
- Sodium bromide
|
|
|
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
|
anat (n/s/m/p/4/e/b/d/c/a/f/l/g)/phys/devp
|
noco (m/d/e/h/v/s)/cong/tumr, sysi/epon, injr
|
proc, drug (N1A/2AB/C/3/4/7A/B/C/D)
|
|
|
|
Hypnotics/sedatives (N05C)
|
|
GABAA
agonists/PAMs |
|
|
GABAB
agonists |
- 1,4-Butanediol
- Aceburic acid
- GABOB
- GHB (Sodium oxybate)
- GBL
- GVL
|
|
H1 inverse
agonists |
Antihistamines: |
- Captodiame
- Cyproheptadine
- Diphenhydramine
- Doxylamine
- Hydroxyzine
- Methapyrilene
- Pheniramine
- Promethazine
- Propiomazine
|
|
Antidepressants |
- Tricyclic antidepressants
- Amitriptyline
- Doxepin
- Trimipramine, etc.
- Tetracyclic antidepressants
- Mianserin
- Mirtazapine, etc.
|
|
Antipsychotics |
- Typical antipsychotics
- Chlorpromazine
- Thioridazine, etc.
- Atypical antipsychotics
- Olanzapine
- Quetiapine
- Risperidone, etc.
|
|
|
α1-Adrenergic
antagonists |
Antidepressants |
- Serotonin antagonists and reuptake inhibitors
- Tricyclic antidepressants
- Amitriptyline
- Doxepin
- Trimipramine, etc.
- Tetracyclic antidepressants
|
|
Antipsychotics |
- Typical antipsychotics
- Chlorpromazine
- Thioridazine, etc.
- Atypical antipsychotics
- Olanzapine
- Quetiapine
- Risperidone, etc.
|
|
Others: |
|
|
|
α2-Adrenergic
agonists |
- 4-NEMD
- Clonidine
- Detomidine
- Dexmedetomidine
- Lofexidine
- Medetomidine
- Romifidine
- Tizanidine
- Xylazine
|
|
5-HT2A
antagonists |
Antidepressants |
- Serotonin antagonists and reuptake inhibitors
- Tricyclic antidepressants
- Amitriptyline
- Doxepin
- Trimipramine, etc.
- Tetracyclic antidepressants
- Mianserin
- Mirtazapine, etc.
|
|
Antipsychotics |
- Typical antipsychotics
- Chlorpromazine
- Thioridazine, etc.
- Atypical antipsychotics
- Olanzapine
- Quetiapine
- Risperidone, etc.
|
|
Others: |
- Eplivanserin
- Niaprazine
- Pruvanserin
- Volinanserin
|
|
|
Melatonin
agonists |
- Agomelatine
- LY-156,735
- Melatonin
- Ramelteon
- Tasimelteon
|
|
Orexin
antagonists |
- Almorexant
- SB-334,867
- SB-408,124
- SB-649,868
- Suvorexant
- TCS-OX2-29
|
|
Others |
- Acecarbromal
- Apronal
- Bromisoval
- Cannabidiol
- Carbromal
- Embutramide
- Evoxine
- Fenadiazole
- Gabapentin
- Kavalactones
- Mephenoxalone
- Opioids
- Passion flower
- Scopolamine
- UMB68
- Valnoctamide
|
|
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
English Journal
- Valnoctamide, which reduces rat brain arachidonic acid turnover, is a potential non-teratogenic valproate substitute to treat bipolar disorder.
- Modi HR1, Ma K1, Chang L1, Chen M1, Rapoport SI2.
- Psychiatry research.Psychiatry Res.2017 Aug;254:279-283. doi: 10.1016/j.psychres.2017.04.048. Epub 2017 Apr 26.
- PMID 28500975
- Valnoctamide Inhibits Cytomegalovirus Infection in Developing Brain and Attenuates Neurobehavioral Dysfunctions and Brain Abnormalities.
- Ornaghi S1,2,3, Hsieh LS1, Bordey A1,4, Vergani P5, Paidas MJ2, van den Pol AN6.
- The Journal of neuroscience : the official journal of the Society for Neuroscience.J Neurosci.2017 Jul 19;37(29):6877-6893. doi: 10.1523/JNEUROSCI.0970-17.2017. Epub 2017 Jun 19.
- PMID 28630251
- A randomized, double-blind, placebo- and risperidone-controlled study on valnoctamide for acute mania.
- Weiser M1,2, Levi L1, Levine SZ3, Bialer M4, Shekh-Ahmad T4, Matei V5, Tiugan A6, Cirjaliu D7, Sava C8, Sinita E9, Zamora D10, Davis JM11.
- Bipolar disorders.Bipolar Disord.2017 Jun;19(4):285-294. doi: 10.1111/bdi.12506. Epub 2017 Jun 12.
- PMID 28605109
Japanese Journal
- In vivo study of the effect of valpromide and valnoctamide in the pilocarpine rat model for focal epilepsy
- 高分子と医薬品との相互作用-5-橋かけ高分子電解質による錠剤の崩壊機構
- 平田 五一
- 薬学雑誌 90(2), 114-119, 1970-02
- … In order to examine the application of tablets of polyelectrolytes, crosslinked with divinylbenzene to a low degree, to disintegration agent, two kinds of materials with different degree of swelling, crosslinked polyacrylic acid and crosslinked polymethacrylic acid, were selected and their disintegration behavior was examined from the point of swelling and fluidity, in the disintegration of valnoctamide tablet, which is extremely difficult to disintegrate, in water, and in the presence of inorganic salts or dl-methylephedrine hydrochloride. …
- NAID 110003654334
- 高分子と医薬品との相互作用(第5報) : 橋かけ高分子電解質による錠剤の崩壊機構
- 平田 五一
- 藥學雜誌 90(2), 114-119, 1970
- … In order to examine the application of tablets of polyelectrolytes, crosslinked with divinylbenzene to a low degree, to disintegration agent, two kinds of materials with different degree of swelling, crosslinked polyacrylic acid and crosslinked polymethacrylic acid, were selected and their disintegration behavior was examined from the point of swelling and fluidity, in the disintegration of valnoctamide tablet, which is extremely difficult to disintegrate, in water, and in the presence of inorganic salts or dl-methylephedrine hydrochloride. …
- NAID 130007286499
Related Links
- Valnoctamide (INN, USAN) has been used in France as a sedative-hypnotic since 1964. It is a structural isomer of valpromide, a valproic acid prodrug; unlike valpromide, however, valnoctamide is not transformed into its homologous acid, ...